Workflow
爱尔眼科(300015) - 2025 Q1 - 季度财报
300015Aier(300015)2025-04-24 13:00

Financial Performance - The company's revenue for Q1 2025 reached ¥6,026,140,250.98, representing a 15.97% increase compared to ¥5,196,134,001.26 in the same period last year[4] - Net profit attributable to shareholders was ¥1,049,755,960.40, up 16.71% from ¥899,476,291.54 year-on-year[4] - The net profit excluding non-recurring gains and losses was ¥1,060,021,212.23, reflecting a 25.78% increase from ¥842,752,224.61 in the previous year[4] - The total operating revenue for the current period reached ¥6,026,140,250.98, an increase of 15.9% compared to ¥5,196,134,001.26 in the previous period[19] - The net profit for the current period was ¥1,166,518,961.07, representing a growth of 20% from ¥972,413,908.00 in the previous period[20] Cash Flow - The net cash flow from operating activities increased by 41.04% to ¥1,820,785,553.45, compared to ¥1,290,939,304.47 in the same quarter last year[4] - Cash inflow from operating activities totaled $5,925,050,230.60, an increase of 12.7% compared to $5,256,300,803.12 in the previous period[23] - Cash inflow from investment activities was $136,567,500.65, significantly higher than $14,369,609.29 in the previous period[24] - The net increase in cash and cash equivalents was $848,009,119.70, compared to an increase of $540,381,588.54 in the prior period[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥34,584,514,506.23, a 4.00% increase from ¥33,255,307,267.70 at the end of the previous year[4] - The total liabilities rose to ¥11,517,307,301.56, up from ¥11,443,294,269.98, indicating a slight increase of 0.65%[18] - The total current assets increased to CNY 10,821,255,475.95 from CNY 9,666,106,195.29, reflecting a growth of approximately 11.93%[16] Shareholder Equity - The equity attributable to shareholders increased by 5.43% to ¥21,839,804,852.20 from ¥20,714,588,364.92 at the end of the previous year[4] - The equity attributable to the parent company reached ¥21,839,804,852.20, an increase of 5.4% from ¥20,714,588,364.92[18] - The basic earnings per share rose to ¥0.1136, a 16.39% increase from ¥0.0976 in the same period last year[4] - The diluted earnings per share also increased by 16.87% to ¥0.1136 from ¥0.0972 year-on-year[4] Operational Efficiency - The company reported a significant increase in cash flow, indicating improved operational efficiency and financial health[4] - The weighted average return on equity was 4.93%, up from 4.67% in the previous year[4] - The total operating costs amounted to ¥4,570,692,763.37, up 13.7% from ¥4,021,509,579.51 in the prior period[19] Investments and R&D - The company has invested in intangible assets totaling ¥999,230,134.45, up from ¥860,585,187.85, indicating a focus on technology and innovation[18] - The company’s research and development expenses for the current period were ¥78,772,510.94, slightly higher than ¥74,654,886.82 in the previous period, reflecting ongoing investment in new technologies[19] - The company plans to continue expanding its market presence and investing in new technologies and products[12] Shareholder Information - The total number of shares held by the top 10 shareholders includes 3,202,323,587 shares held by the controlling shareholder, representing 79.99% of the total shares[12] - The total number of restricted shares at the end of the period is 1,396,055,322, with no changes during the current period[14] - The company’s actual controller holds 360,947,973 shares, which is approximately 10.00% of the total shares[12] - The company has a strategy to unlock 25% of the restricted shares annually based on the previous year's holdings[14]